(Reuters) – Europe’s medicines regulator said on Friday an investigation had so far revealed that a limited number of third-party documents were unlawfully accessed in a cyberattack and that it had engaged an external agency to carry out a full probe.
U.S. drugmaker Pfizer and German partner BioNTech said on Dec. 9 that documents relating to their COVID-19 vaccine were accessed unlawfully after the regulator disclosed the incident on the same day.
(Reporting by Yadarisa Shabong in Bengaluru; Editing by Anil D’Silva)
